Cargando…
Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
BACKGROUND: COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to det...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189812/ https://www.ncbi.nlm.nih.gov/pubmed/34123422 http://dx.doi.org/10.1155/2021/5585291 |
_version_ | 1783705562621411328 |
---|---|
author | Tseng, Luke Hittesdorf, Erin Berman, Mitchell F. Jordan, Desmond A. Yoh, Nina Elisman, Katerina Eiseman, Katherine A. Miao, Yuqi Wang, Shuang Wagener, Gebhard |
author_facet | Tseng, Luke Hittesdorf, Erin Berman, Mitchell F. Jordan, Desmond A. Yoh, Nina Elisman, Katerina Eiseman, Katherine A. Miao, Yuqi Wang, Shuang Wagener, Gebhard |
author_sort | Tseng, Luke |
collection | PubMed |
description | BACKGROUND: COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to deteriorate. METHODS: This is a retrospective cohort study of all COVID-19 patients admitted to a tertiary academic medical center in New York City during the COVID-19 crisis in spring 2020. The primary combined endpoint included intubation, stage 3 acute kidney injury (AKI), or death. Laboratory tests available on admission in at least 70% of patients (and age) were included for univariate analysis. Tests that were statistically or clinically significant were then included in a multivariate binary logistic regression model using stepwise exclusion. 70% of all patients were used to train the model, and 30% were used as an internal validation cohort. The aim of this study was to develop and validate a model for COVID-19 severity based on biomarkers. RESULTS: Out of 2545 patients, 833 (32.7%) experienced the primary endpoint. 53 laboratory tests were analyzed, and of these, 47 tests (and age) were significantly different between patients with and without the endpoint. The final multivariate model included age, albumin, creatinine, C-reactive protein, and lactate dehydrogenase. The area under the ROC curve was 0.850 (CI [95%]: 0.813, 0.889), with a sensitivity of 0.800 and specificity of 0.761. The probability of experiencing the primary endpoint can be calculated as p=e((−2.4475+0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH))/1+e((−2.4475+ 0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH)). CONCLUSIONS: Our study demonstrated that poor outcome in COVID-19 patients can be predicted with good sensitivity and specificity using a few laboratory tests. This is useful for identifying patients at risk during admission. |
format | Online Article Text |
id | pubmed-8189812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-81898122021-06-11 Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score Tseng, Luke Hittesdorf, Erin Berman, Mitchell F. Jordan, Desmond A. Yoh, Nina Elisman, Katerina Eiseman, Katherine A. Miao, Yuqi Wang, Shuang Wagener, Gebhard Crit Care Res Pract Research Article BACKGROUND: COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to deteriorate. METHODS: This is a retrospective cohort study of all COVID-19 patients admitted to a tertiary academic medical center in New York City during the COVID-19 crisis in spring 2020. The primary combined endpoint included intubation, stage 3 acute kidney injury (AKI), or death. Laboratory tests available on admission in at least 70% of patients (and age) were included for univariate analysis. Tests that were statistically or clinically significant were then included in a multivariate binary logistic regression model using stepwise exclusion. 70% of all patients were used to train the model, and 30% were used as an internal validation cohort. The aim of this study was to develop and validate a model for COVID-19 severity based on biomarkers. RESULTS: Out of 2545 patients, 833 (32.7%) experienced the primary endpoint. 53 laboratory tests were analyzed, and of these, 47 tests (and age) were significantly different between patients with and without the endpoint. The final multivariate model included age, albumin, creatinine, C-reactive protein, and lactate dehydrogenase. The area under the ROC curve was 0.850 (CI [95%]: 0.813, 0.889), with a sensitivity of 0.800 and specificity of 0.761. The probability of experiencing the primary endpoint can be calculated as p=e((−2.4475+0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH))/1+e((−2.4475+ 0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH)). CONCLUSIONS: Our study demonstrated that poor outcome in COVID-19 patients can be predicted with good sensitivity and specificity using a few laboratory tests. This is useful for identifying patients at risk during admission. Hindawi 2021-05-31 /pmc/articles/PMC8189812/ /pubmed/34123422 http://dx.doi.org/10.1155/2021/5585291 Text en Copyright © 2021 Luke Tseng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tseng, Luke Hittesdorf, Erin Berman, Mitchell F. Jordan, Desmond A. Yoh, Nina Elisman, Katerina Eiseman, Katherine A. Miao, Yuqi Wang, Shuang Wagener, Gebhard Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score |
title | Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score |
title_full | Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score |
title_fullStr | Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score |
title_full_unstemmed | Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score |
title_short | Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score |
title_sort | predicting poor outcome of covid-19 patients on the day of admission with the covid-19 score |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189812/ https://www.ncbi.nlm.nih.gov/pubmed/34123422 http://dx.doi.org/10.1155/2021/5585291 |
work_keys_str_mv | AT tsengluke predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT hittesdorferin predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT bermanmitchellf predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT jordandesmonda predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT yohnina predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT elismankaterina predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT eisemankatherinea predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT miaoyuqi predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT wangshuang predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score AT wagenergebhard predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score |